Getty ImagesThe share price of . gained 2.38 per cent to Rs 584.65 at 11:52AM (IST) in Friday's trade. The stock has hit a high of Rs 587.05 and low of Rs 570.6 so far during the session. The stock had closed at Rs 571.05 in the previous session.
The counter has had a total traded volume of 45549 shares so far with a value of Rs 2.63 crore on the NSE. It traded at a price-to-earnings multiple of 12.88 and a price-to-book ratio of 1.59.
A higher P/E ratio shows investors are willing to pay a higher price for per rupee earnings given by the stock because of better future growth expectations.
The price-to-book value indicates the inherent value of a company and reflects the price investors are willing to pay even for no growth in the business.
The scrip declined 35.66 per cent during the past one year, while the 30-share index advanced 8.74 per cent during the same period.
Aurobindo Pharma Ltd. belongs to the Pharma - Indian industry.
Promotor/FII Holding
Promoters held 48.76 per cent stake in the company as of 30-Jun-2022, while FIIs and domestic institutional investors ownership stood at 20.71 per cent and 9.82 per cent, respectively.
Key Financials
The firm reported consolidated sales of Rs 5858.25 crore for the quarter ended 31-Mar-2022, down 3.44 per cent from the previous quarter's Rs 6067.21 crore and down 3.64 per cent from the year-ago quarter's Rs 6079.6 crore.
Profit for the latest quarter stood at Rs 576.46 crore, down 28.08 per cent from the same quarter a year ago.
The counter has had a total traded volume of 45549 shares so far with a value of Rs 2.63 crore on the NSE. It traded at a price-to-earnings multiple of 12.88 and a price-to-book ratio of 1.59.
A higher P/E ratio shows investors are willing to pay a higher price for per rupee earnings given by the stock because of better future growth expectations.
The price-to-book value indicates the inherent value of a company and reflects the price investors are willing to pay even for no growth in the business.
The scrip declined 35.66 per cent during the past one year, while the 30-share index advanced 8.74 per cent during the same period.
Aurobindo Pharma Ltd. belongs to the Pharma - Indian industry.
Promotor/FII Holding
Promoters held 48.76 per cent stake in the company as of 30-Jun-2022, while FIIs and domestic institutional investors ownership stood at 20.71 per cent and 9.82 per cent, respectively.
Key Financials
The firm reported consolidated sales of Rs 5858.25 crore for the quarter ended 31-Mar-2022, down 3.44 per cent from the previous quarter's Rs 6067.21 crore and down 3.64 per cent from the year-ago quarter's Rs 6079.6 crore.
Profit for the latest quarter stood at Rs 576.46 crore, down 28.08 per cent from the same quarter a year ago.
Experience Your Economic Times Newspaper, The Digital Way!
Read More News on
(What's moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.)
...moreDownload The Economic Times News App to get Daily Market Updates & Live Business News.
Pick the best stocks for yourself
Powered by